{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:16:12Z","timestamp":1790532972336,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Parasitology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vetpar.2006.12.022","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T11:17:53Z","timestamp":1175167073000},"page":"25-34","source":"Crossref","is-referenced-by-count":28,"title":["Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors"],"prefix":"10.1016","volume":"146","author":[{"given":"Ana Claudia","family":"Granthon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina V.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliany C.F.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cammerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Orenes","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A.","family":"Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderley","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vetpar.2006.12.022_bib1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/AAC.49.5.1679-1687.2005","article-title":"Antileishmanial activity of terpene nerolidol","volume":"49","author":"Arruda","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.vetpar.2006.12.022_bib2","series-title":"Emerging Targets in Antibacterial and Antifungal Chemotherapy","first-page":"410","article-title":"Biochemical aspects of ergosterol biosynthesis inhibitors","author":"Barrett-Bee","year":"1992"},{"key":"10.1016\/j.vetpar.2006.12.022_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India","volume":"38","author":"Bhattacharya","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vetpar.2006.12.022_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijantimicag.2003.12.009","article-title":"Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi","volume":"24","author":"Braga","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.vetpar.2006.12.022_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1389557043487439","article-title":"Antiprotozoal lysophospholipid analogues: a comparison of their activity against trypanosomatid parasites and tumor cells","volume":"4","author":"Castro","year":"2004","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.vetpar.2006.12.022_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0006-2952(96)00903-3","article-title":"Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors","volume":"53","author":"Contreras","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.vetpar.2006.12.022_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ijantimicag.2003.11.005","article-title":"Selective anti-Toxoplasma gondii activities of azasterols","volume":"23","author":"Dantas-Leite","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.vetpar.2006.12.022_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0020-7519(03)00008-0","article-title":"Programmed cell death in trypanosomatids and other unicellular organisms","volume":"33","author":"Debrabant","year":"2003","journal-title":"Int. J. Parasitol."},{"issue":"6","key":"10.1016\/j.vetpar.2006.12.022_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4269\/ajtmh.2001.65.685","article-title":"Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi","volume":"65","author":"Dietze","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vetpar.2006.12.022_bib10","first-page":"2","article-title":"Oral miltefosine may revolutionize treatment of visceral leishmaniasis. The potential impact of miltefosine on visceral leishmaniasis in India","volume":"68","author":"Ganguly","year":"2002","journal-title":"TDR News"},{"key":"10.1016\/j.vetpar.2006.12.022_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/bj3080031","article-title":"Effects of an azasterol inhibitor of sterol 24-transmethylation on sterol biosynthesis and growth of Leishmania donovani promastigotes","volume":"308","author":"Haughan","year":"1995","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.vetpar.2006.12.022_bib12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","article-title":"Hexadecylphosphocoline: oral treatment of visceral leishmaniasis in mice","volume":"36","author":"Kuhlencord","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.vetpar.2006.12.022_bib13","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/AAC.34.11.2097","article-title":"Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi","volume":"34","author":"Lazardi","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.vetpar.2006.12.022_bib14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0924-8579(03)00211-5","article-title":"Leishmaniasis: efflux pumps and chemoresistance","volume":"22","author":"Leandro","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.vetpar.2006.12.022_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jac\/47.5.537","article-title":"Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole","volume":"47","author":"Lira","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.vetpar.2006.12.022_bib16","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1128\/AAC.48.8.2937-2950.2004","article-title":"Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis","volume":"48","author":"Lorente","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.vetpar.2006.12.022_bib17","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1016\/j.bmc.2005.02.060","article-title":"Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa","volume":"13","author":"Lorente","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.vetpar.2006.12.022_bib18","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1021\/jm021114j","article-title":"Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruzi","volume":"46","author":"Magaraci","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.vetpar.2006.12.022_bib19","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm0002578","article-title":"Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy","volume":"44","author":"Martin","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.vetpar.2006.12.022_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001432-200210000-00005","article-title":"Recent developments in leishmaniasis","volume":"15","author":"Melby","year":"2002","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.vetpar.2006.12.022_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0035-9203(94)90446-4","article-title":"Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus","volume":"88","author":"Molina","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vetpar.2006.12.022_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/14787210.2.2.279","article-title":"Progress in the treatment of a neglected infectious disease: visceral leishmaniasis","volume":"2","author":"Murray","year":"2004","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.vetpar.2006.12.022_bib23","series-title":"Emerging Targets in Antibacterial and Antifungal Chemotherapy","first-page":"410","article-title":"Rationally designed inhibitors of sterol biosynthesis","author":"Oehlschlager","year":"1992"},{"key":"10.1016\/j.vetpar.2006.12.022_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbamem.2004.01.010","article-title":"Hexadecylphosphocholine interaction with lipid monolayers","volume":"1661","author":"Rakotomanga","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.vetpar.2006.12.022_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(02)00280-3","article-title":"Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa","volume":"126","author":"Roberts","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vetpar.2006.12.022_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1550-7408.2001.tb00195.x","article-title":"The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin-permeabilization","volume":"48","author":"Rodrigues","year":"2001","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.vetpar.2006.12.022_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/AAC.46.2.487-499.2002","article-title":"Ultrastructural and biochemical alterations induced by 22,26-azasterol, a \u039424(25)-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis","volume":"46","author":"Rodrigues","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.vetpar.2006.12.022_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.exppara.2005.08.006","article-title":"Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensis","volume":"111","author":"Rodrigues","year":"2005","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.vetpar.2006.12.022_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0022-3859.926","article-title":"Recent understanding in the treatment of visceral leishmaniasis","volume":"49","author":"Rosenthal","year":"2003","journal-title":"J. Postgrad. Med."},{"issue":"8","key":"10.1016\/j.vetpar.2006.12.022_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.cdd.4401435","article-title":"Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani","volume":"11","author":"Sen","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.vetpar.2006.12.022_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-4017(01)00595-7","article-title":"Evaluation of terbinafine treatment in Leishmania chagasi-infected hamsters (Mesocricetus auratus)","volume":"103","author":"Sim\u00f5es-Mattos","year":"2002","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2006.12.022_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-003-0201-2","article-title":"Miltefosine (Impavido\u00ae): the first oral treatment against leishmaniasis","volume":"193","author":"Sinderman","year":"2004","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.vetpar.2006.12.022_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbiopara.2005.01.014","article-title":"Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani","volume":"141","author":"Singh","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.vetpar.2006.12.022_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"issue":"1","key":"10.1016\/j.vetpar.2006.12.022_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trstmh.2006.03.010","article-title":"Mechanisms of action of lysophospholipid analogues against trypanosomatid parasites","volume":"100","author":"Urbina","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"Suppl.","key":"10.1016\/j.vetpar.2006.12.022_bib36","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1017\/S0031182097001194","article-title":"Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites","volume":"114","author":"Urbina","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.vetpar.2006.12.022_bib37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s001090050359","article-title":"Chemotherapy of Chagas\u2019 disease: the how and the why","volume":"77","author":"Urbina","year":"1999","journal-title":"J. Mol. Med."},{"issue":"7","key":"10.1016\/j.vetpar.2006.12.022_bib38","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/AAC.48.7.2379-2387.2004","article-title":"In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi","volume":"48","author":"Urbina","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.vetpar.2006.12.022_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-6851(02)00206-2","article-title":"Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana","volume":"125","author":"Urbina","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vetpar.2006.12.022_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1381612023396230","article-title":"Cell biology of Leishmania spp.: invading and evading","volume":"8","author":"Vannier-Santos","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.vetpar.2006.12.022_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1550-7408.1995.tb01591.x","article-title":"Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania","volume":"42","author":"Vannier-Santos","year":"1995","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.vetpar.2006.12.022_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0924-8579(96)00325-1","article-title":"Ultrastructural alterations in Trypanosoma (Schizotrypanum) cruzi induced by a \u039424(25)-sterol methyltransferase inhibitors and their combinations with ketoconazole","volume":"7","author":"Vivas","year":"1996","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.vetpar.2006.12.022_bib43","unstructured":"WHO, 2002. Epidemiological Bulletin\/PAHO, vol. 23, No. 3."}],"container-title":["Veterinary Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304401707000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304401707000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T03:26:33Z","timestamp":1587439593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304401707000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0304401707000076"],"URL":"https:\/\/doi.org\/10.1016\/j.vetpar.2006.12.022","relation":{},"ISSN":["0304-4017"],"issn-type":[{"value":"0304-4017","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}